Shaji Kumar, MD, presents the case of a 63-year-old woman with R/R multiple myeloma and discusses how recent data updates of bispecifics influence treatment decision-making for patients.
Case Based Peer Perspectives
Expert oncologist Terence Friedlander, MD, discusses the case of a 75-year-old woman with muscle-invasive bladder cancer and reviews the options for treatment in the adjuvant setting.
Expert oncologist Jason Porter, MD, centers discussion on a patient case of non–small cell lung cancer and highlights novel treatment modalities in this setting.
Eric Jonasch, MD, presents the case of a 72-year-old male with advanced renal cell carcinoma (RCC) and discusses how recent data updates influence treatment decision-making.
Centering his discussion on a patient case of metastatic melanoma, expert oncologist Sajeve Thomas, MD, reflects on the current treatment paradigm and highlights best practices in care.
Rana McKay, MD, presents the case of a 73-year-old man with advanced renal cell carcinoma (RCC) and reviews how recent data updates influence treatment decision-making.
Sheela Tejwani, MD, reviews the case of an 83-year-old man with biochemically recurrent mCSPC and discusses the possible treatment approaches.
Expert oncologist, Daniel George, MD, reviews the case of 68-year-old woman who is diagnosed and treated for advanced renal cell carcinoma.
Centering discussion on a patient case of endometrial cancer, expert oncologist Bhavana Pothuri, MD, highlights systemic therapy and best practices in this setting.
Marc Matrana, MD discusses the case of a man with mCSPC and reviews the current state of the mCSPC treatment landscape including both approved and emerging treatment options.
Ian Flinn, MD, PhD, reviews the case of a 68-year-old man with two relapses of DLBCL, discusses the challenges of R/R DLBCL management and the potential treatment options, and highlights the critical needs of such patients.
Gilles Salles, MD, PhD, presents the case of a woman with relapsed/refractory DLBCL who refused stem cell transplant and CAR T-cell therapy, explains the available third-line treatment options, and discusses clinical trial data on a promising combination therapy.
Matthew Lunning, DO, FACP, presents the case of a man with diffuse large B-cell lymphoma and reviews the available treatment options, including options after relapse and chemorefractory disease.
Grzegorz S. Nowakowski, MD, reviews the case of a 76-year-old woman with DLBCL and discusses the available treatment options, including options after relapse.
Dr Catherine Coombs discusses considerations for treatment selection in the context of a patient case with relapsed/refractory chronic lymphocytic leukemia.
Raajit Rampal, MD, PhD, reviews the case of a 67-year-old man with primary myelofibrosis.
Expert perspectives on the diagnosis and management of uncontrolled polycythemia vera in a 60-year-old man.
Expert hematologist-oncologist Ajay Nooka, MD, MPH, FACP, centers discussion around a clinical case to review updates in the treatment of newly diagnosed multiple myeloma.
Expert hematologist-oncologist Rafael Fonseca, MD, reviews the diagnosis and management of an 81-year-old-man who presents with transplant-ineligible multiple myeloma.
Expert oncologist Zofia Piotrowska, MD, reviews the case of a 59-year-old woman who is diagnosed and treated for EGFR exon 20–positive non–small cell lung cancer.
Expert Joel Neal, MD, PhD, speaks to the management of a 64-year-old man diagnosed with EGFR exon20 insertion–positive NSCLC.
John Mascarenhas, MD, reviews the case of a 76-year-old woman with myelofibrosis and her treatment with pacritinib.
Srdan Verstovsek, MD, PhD, provides insight on treatment of primary myelofibrosis, including ruxolitinib, and comments on some of the challenges, unmet needs, and future directions in the field.
Dr John Allan reviews the case of a 70-year-old woman with newly diagnosed CLL and discusses current treatment strategies and challenges.
Pashna Munshi, MD, comments on available treatments for steroid-refractory chronic graft-versus-host disease (cGVHD), including ruxolitinib, and discusses challenges to diagnosis and management of the disease.
Yi-Bin Chen, MD, provides insight on treatment of steroid-refractory chronic GVHD with ruxolitinib.
Expert Leslie Randall, MD, discusses the case of a 71-year-old woman who is diagnosed with ovarian cancer. Dr. Randall reviews data with PARP inhibitors and rationale for use of maintenance therapy in patients with platinum-sensitive disease.
Marcia S. Brose, MD, PhD, discusses 2 patient cases of differentiated thyroid cancer (DTC) and explains the DTC treatment landscape.
Expert oncologist Michael Birrer, MD, PhD, reviews the case of a 70-year-old woman with advanced endometrial carcinoma and considers her ideal treatment pathway.
Kevin Kalinsky, MD, MS, provides guidance on treating a patient with HR-positive breast cancer with a CDK4/6 inhibitor, and recommends management strategies for patients who develop relapsed disease.